Form 4 for CNMD CONMED Corp
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-04 · accession 0001127602-21-028439 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-05 | 2021-11-04 | CNMD | Pelletier Johonna Marie | VP, Treas, Tax | S - Sale+OE | $154.52 | -9,197 | 2,634 | -78% | -$1.42M |
| DM | 2021-11-05 | 2021-11-04 | CNMD | Pelletier Johonna Marie | VP, Treas, Tax | M - OptEx | $84.83 | +7,950 | 8,034 | +9,464% | +$674.4K |
| DM | 2021-11-05 | 2021-11-04 | CNMD | Pelletier Johonna Marie | VP, Treas, Tax | M - OptEx | $0.00 | -7,950 | 10.2K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | S | D | 1,247 | $154.14 | 2,634 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-04 | M | A | 2,550 | $97.69 | 5,184 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-04 | S | D | 5,400 | $154.56 | 2,634 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-04 | M | A | 5,400 | $78.76 | 8,034 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-04 | S | D | 2,550 | $154.62 | 2,634 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.53 to $154.64. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 6 | Derivative | Options To Purchase Common Stock | 2021-11-04 | M | D | 5,400 | $0.00 | 8,100 | D | $78.76 · — to 2029-03-01 | 5,400 Common Stock | (F2) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 7 | Derivative | Options To Purchase Common Stock | 2021-11-04 | M | D | 2,550 | $0.00 | 10,200 | D | $97.69 · — to 2030-03-02 | 2,550 Common Stock | (F2) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |